In vivo kinetic degradation analysis and biocompatibility of aliphatic polyester polyurethanes

Journal of Biomedical Materials Research - Part A

Volumn 94, Issue 2, 2010, Pages 333-343

  Knight, Pamela T ^a,b   Kirk, James T ^c   Anderson, James M ^a,c,d   Mather, Patrick T ^b,e  

^a Case Western Reserve University   (United States)

^b SYRACUSE UNIVERSITY   (United States)

^c Case Western Reserve University   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e Syracuse University   (United States)

Author keywords

Biocompatibility; Biodegradation; In vivo; Kinetics; Polyester polyurethane

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; BIOLOGICAL MEMBRANES; DEGRADATION; MICROBIOLOGY; MOLECULAR WEIGHT; POLYMERS; POLYURETHANES; TOXIC MATERIALS;

ALIPHATIC POLYESTER; BLOCK COMPOSITION; CHRONIC INFLAMMATION; CHRONIC INFLAMMATORY; CRYSTALLINITIES; DEGRADATION ANALYSIS; DEGRADATION RATE; FIBROUS CAPSULE FORMATION; FOREIGN BODY GIANT CELLS; FOREIGN BODY REACTIONS; HARD BLOCKS; HEAT OF FUSION; HISTOLOGICAL ANALYSIS; IN-VITRO; IN-VIVO; INFLAMMATORY RESPONSE; INITIAL MOLECULAR WEIGHT; KINETIC ANALYSIS; MASS LOSS; MELTING TEMPERATURES; RAPID RESOLUTION; SOFT SEGMENTS;

BIODEGRADABLE POLYMERS;

POLYESTER; POLYHEDRAL OLIGOSILSESQUIOXANE; POLYURETHAN; UNCLASSIFIED DRUG; BIOMATERIAL; ORGANOSILICON DERIVATIVE; POLYCAPROLACTONE; POLYHEDRALOLIGOSILSESQUIOXANE; POLYLACTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BIOCOMPATIBILITY; BIODEGRADABILITY; BIODEGRADABLE IMPLANT; CHRONIC INFLAMMATION; CONFERENCE PAPER; CONTROLLED STUDY; CRYSTAL STRUCTURE; FOREIGN BODY REACTION; GIANT CELL; HISTOPATHOLOGY; MACROPHAGE; MELTING POINT; MOLECULAR WEIGHT; NONHUMAN; RAT; SURFACE PROPERTY; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; IMPLANT; KINETICS; MATERIALS TESTING; METABOLISM; PATHOLOGY;

ANIMALS; BIOCOMPATIBLE MATERIALS; FOREIGN-BODY REACTION; GIANT CELLS, FOREIGN-BODY; IMPLANTS, EXPERIMENTAL; KINETICS; MATERIALS TESTING; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; ORGANOSILICON COMPOUNDS; POLYESTERS; POLYURETHANES; RATS;

EID: 77953846248     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32806     Document Type: Conference Paper

References (28)

1. Santerre JP, Woodhouse K, Laroche G, Labow RS. Understanding the biodegradation of polyurethanes: From classical implants to tissue engineering materials. Biomaterials 2005;26:7457-7470.
2. Sivak WN, Pollack IF, Petoud S, Zamboni WC, Zhang J, Beckman EJ. LDI-glycerol polyurethane implants exhibit controlled release of DB-67 and anti-tumor activity in vitro against malignant gliomas. Acta Biomaterialia 2008;4:852-862.
3. Adhikari R, Gunatillake PA, Griffiths I, Tatai L, Wickramaratna M, Houshyar S, Moore T, Mayadunne RTM, Field J, McGee M, Carbone T. Biodegradable injectable polyurethanes: Synthesis and evaluation for orthopedic applications. Biomaterials 2008;29:3762-3770.
4. Bruin P, Smedinga J, Pennings AJ, Jonkman MF. Biodegradable lysine diisocyanate-based poly(glycolide-co-e-caprolactone) urethane network in artificial skin. Biomaterials 1990;11:291-295.
5. Zhang JY, Beckman EJ, Piesco NP, Agarwal S. A new peptide-based urethane polymer: Synthesis, biodegradation, and potential to support cell growth in vitro. Biomaterials 2000;21:1247-1258.
6. Knight PT, Lee KM, Qin H, Mather PT. Biodegradable thermoplastic polyurethanes incorporating polyhedral oligosilsesquioxane. Biomacromolecules 2008;9:2458-2467.
7. Skarja GA, Woodhouse KA. Structure-property relationships of degradable polyurethane elastomers containing an amino acid-based chain extender. J Appl Polym Sci 2000;75:1522-1534.
8. Woo GL, Mittelman MW, Santerre JP. Synthesis and characterization of a novel biodegradable antimicrobial polymer. Biomaterials 2000;21:1235-1246.
9. Kannan RY, Salacinski HJ, Edirisinghe MJ, Hamilton G, Seifalian AM. Polyhedral oligomeric silsesquioxane-polyurethane nanocomposite microvessels for an artificial capillary bed. Biomaterials 2006;27:4618-4626.
10. Kannan RY, Salacinski HJ, Ghanavi J-E, Narula A, Odlyha M, Peirovi H, Butler PE, Seifalian AM. Silsesquioxane nanocomposites as tissue implants. Plast Reconstruct Surg 2007;119:1653-1662.
11. Dey J, Xu H, Shen J, Thevenot P, Gondi SR, Nguyen KT, Sumerlin BS, Tang L, Yang J. Development of biodegradable crosslinked urethane-doped polyester elastomers. Biomaterials 2008;29:4637-4649.
12. Henry JA, Burugapalli K, Neuenschwander P, Pandit A. Structural variants of biodegradable polyesterurethane in vivo evoke a cellular and angiogenic response that is dictated by architecture. Acta Biomaterialia 2009;5:29-42.
13. van Minnen B, van Leeuwen MBM, Kors G, Zuidema J, van Kooten TG, Bos RRM. In vivo resorption of a biodegradable polyurethane foam, based on 1,4-butanediisocyanate: A three-year subcutaneous implantation study. J BiomedMater Res A 2008;85:972-982.
14. Borkenhagen M, Stoll RC, Neuenschwander P, Suter UW, Aebischer P. In vivo performance of a new biodegradable polyester urethane system used as a nerve guidance channel. Biomaterials 1998;19:2155-2165.
15. Christenson EM, Dadsetan M, Anderson JM, Hiltner A. Biostability and macrophage-mediated foreign body reaction of silicone-modified polyurethanes. J Biomed Mater Res A 2005;74:141-155.
16. Ward R, Anderson J, McVenes R, Stokes K. In vivo biostability of shore 55D polyether polyurethanes with and without fluoropolymer surface modifying endgroups. J Biomed Mater Res A 2006;79:836-845.
17. Guo Q, Knight PT, Mather PT. Tailored drug release from biodegradable stent coatings based on hybrid polyurethanes. J Controlled Release 2009;137:224-233.
18. Rodriguez A, Voskerician G, Meyerson H, MacEwan SR, Anderson JM. T cell subset distributions following primary and secondary implantation at subcutaneous biomaterial implant sites. J Biomed Mater Res A 2008;85:556-565.
19. Voskerician G, Gingras PH, Anderson JM. Macroporous condensed poly(tetrafluoroethylene). I. In vivo inflammatory response and healing characteristics. J Biomed Mater Res A 2006;76:234-242.
20. Voskerician G, Shive MS, Shawgo RS, von Recum H, Anderson JM, Cima MJ, Langer R. Biocompatibility and biofouling of MEMS drug delivery devices. Biomaterials 2003;24:1959-1967.
21. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol 2008;20:86-100.
22. Anderson JM. Perspectives on the in vivo responses of biodegradable polymers. In: Hollinger JO, editor. Biomedical Applications of Synthetic Biodegradable Polymers. New York: CRC Press; 1995. p 223-233.
23. Anderson JM. In vivo biocompatibility of implantable delivery systems and biomaterials. Eur J Pharm Biopharm 1994;40:1-8.
24. Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Delivery Rev 1997;28:5-24.
25. Yamaguchi K, Anderson JM. In vivo biocompatibility studies of Medisorb 65/35 DL-lactide/glycolide copolymer microspheres. J Controlled Release 1993;24(1-3):81-93.
26. Saha SK, Tsuji H. Hydrolytic degradation of amorphous films of L-lactide copolymers with glycolide and D-lactide. Macromol Mater Eng 2006;291:357-368.
27. Tsuji H, Del Carpio CA. In vitro hydrolysis of blends from enantiomeric poly(lactide)s. III. Homocrystallized and amorphous blend films. Biomacromolecules 2003;4:7-11.
28. Goepferich A. Polymer bulk erosion. Macromolecules 1997;30: 2598-2604.